FDA clears US trials of Green Valley’s Alzheimer’s drugChina’s Shanghai Green Valley Pharmaceuticals has clearance to begin a late stage clinical trial to support a US filing Share XFDA clears US trials of Green Valley’s Alzheimer’s drughttps://pharmaphorum.com/news/fda-clears-us-trials-of-green-valleys-of-alzheimers-drug/
Chinese pharma claims first Alzheimer’s drug approval since 2003China’s drugs regulator has conditionally approved Shanghai Green Valley Pharmaceuticals’ Oligomannate to improve cognitive function in mild to Share XChinese pharma claims first Alzheimer’s drug approval since 2003https://pharmaphorum.com/news/chinas-shanghai-green-valley-claims-first-alzheimers-approval-since-2003/
